Health Condition 1: P599- Neonatal jaundice, unspecified
Conditions
Interventions
Intervention1: Oral calcium phosphate: Neonates will receive oral calcium phosphate at a dose of 40-50 mg/kg/day of elemental calcium, administered in two divided doses daily, starting within six hour
Sponsors
Dr Bhabesh Kant Chowdhry
Eligibility
Inclusion criteria
Inclusion criteria: Hemodynamically stable Inborn neonates with a gestational age of 35 weeks or more
Exclusion criteria
Exclusion criteria: 1. Neonates requiring NICU admission 2. Presence of cephalohematoma or subgaleal hematoma 3. Major congenital anomalies 4. Isoimmune haemolytic anemia (Direct coomb s test positive) 5. Parental refusal to provide consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Proportion of neonates required phototherapy until dischargeTimepoint: Until the baby was discharged from the hospital (usually day 3 of life) | — |
Secondary
| Measure | Time frame |
|---|---|
| Duration of phototherapyTimepoint: If baby required phototherapy during the admission, then the duration of phototherapy will be calculated;Rate of rehospitalization for the treatment of neonatal jaundiceTimepoint: Babies readmitted following the discharge for the treatment of neonatal jaundice in the first week of life;Incidence of hypercalcemia between the groupsTimepoint: Serum calcium levels will be measured on day 3 life, concurrently with the universal congenital hypothyroidism screening | — |
Countries
India
Contacts
Public ContactDr Arnab Ghorui
All India Institute of Medical Sciences, Patna
Outcome results
None listed